Pricing Log in Create free account

Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs Shattuck Labs, Inc. (STTK)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Shattuck Labs, Inc. are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Shattuck Labs, Inc. are of similar size ($555.0M and $524.8M). Shattuck Labs, Inc. has the higher net margin (0.00% vs −89,724.2%) and the lower return on invested capital (−1,230.7% vs 0.00%). Across the 13 metrics below, Ceryvyn Therapeutics Ltd. - Unsponsored ADR leads on 7 and Shattuck Labs, Inc. on 6.

Valuation

Metric CYVNY STTK Biotechnology median
P/E n/m n/m 8.50
P/S 2.37 125.47 9.71
P/B n/m 3.33 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 759.28 88.32 9.21
Earnings yield (2,375.00%) (9.41%) (33.15%)
Free cash flow yield (84,379.36%) (5.86%) (25.50%)

Profitability

Metric CYVNY STTK Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (89,724.18%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (39.21%) (56.36%)
Return on assets 0.00% (36.88%) (48.04%)
Return on invested capital 0.00% (1,230.74%) 0.00%

Growth

Metric CYVNY STTK Biotechnology median
Revenue growth (TTM) — 106.48% 6.02%
EPS growth (last fiscal year) 61.59% 53.02% 30.26%
Revenue growth, 5-year CAGR (15.81%) (36.82%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYVNY STTK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.22 27.59 4.72
Net debt to EBITDA 0.31 1.62 0.96

Dividend

Metric CYVNY STTK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYVNY STTK Biotechnology median
Market cap 524.83m 555.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack